Yapan Bio
Hyderabad, India· Est.
India‑based CDMO providing integrated vaccine and biologics manufacturing for global biotech partners.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
India‑based CDMO providing integrated vaccine and biologics manufacturing for global biotech partners.
OncologyImmunology
Technology Platform
Integrated process development and GMP manufacturing platform with BSL‑2+ containment, supporting recombinant vaccines, viral vectors, gene‑therapy constructs, and monoclonal antibodies.
Opportunities
Rising global demand for vaccine and gene‑therapy manufacturing presents strong growth potential for Yapan’s BSL‑2+ services and capacity expansion.
Risk Factors
Regulatory compliance, capacity constraints, and competition from larger multinational CDMOs could limit market share.
Competitive Landscape
Competes with global CDMOs such as Samsung Biologics, Lonza, and WuXi Biologics; differentiates through specialized BSL‑2+ vaccine and gene‑therapy manufacturing capabilities.